Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda

NCT00639938 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

722

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Nevirapine
DRUG: HIV immune globulin solution

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)